|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/519 | |
| C07D 473/00 | |||
| C07D 487/04 | |||
| A61P 29/00 |
| (11) | Patento numeris | 2175859 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08781709.4 |
| Europos patento paraiškos padavimo data | 2008-07-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-04-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-03-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/069813 |
| Data | 2008-07-11 |
| (87) | Numeris | WO 2009/009740 |
| Data | 2009-01-15 |
| (30) | Numeris | Data | Šalis |
| 949328 P | 2007-07-12 | US |
| (72) |
KRASINSKI, Antoni, US
PUNNA, Sreenivas, US
UNGASHE, Solomon, US
WANG, Qiang, US
ZENG, Yibin, US
|
| (73) |
ChemoCentryx, Inc.,
850 Maude Avenue, Mountain View California 94043,
US
|
| (54) | FUSED HETEROARYL PYRIDYL AND PHENYL BENZENESULFONAMIDES AS CCR2 MODULATORS FOR THE TREAMENT OF INFLAMMATION |
| FUSED HETEROARYL PYRIDYL AND PHENYL BENZENESULFONAMIDES AS CCR2 MODULATORS FOR THE TREAMENT OF INFLAMMATION |